Stock listing
NASDAQ:ADIL Adial Pharmaceuticals, Inc Stock
Home listing (NASDAQ) of Adial Pharmaceuticals, Inc
Follow Adial Pharmaceuticals, Inc into a list and get an email when it puts out news.
Share price · NASDAQ:ADIL
$3.81 USD -1.07 (-21.9%)
Close on Oct 30, 2026
- Day range
- $3.02 – $4.94 USDOct 30, 2026
- Volume
- 169,065 sharesOct 30, 2026
- Market cap
- $10.00M USDAt the close on Oct 30, 2026 · price × 2.63M shares outstanding
- Traded on an average day
- $278,249 USDMedian day 50,800 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ADIL · Home | $3.81 USD | -1.07 (-21.9%) | 169,065 | $4.71 | $4.94 | $3.02 | $4.88 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ADIL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.81 | -1.07 | -21.9% | $4.71 | $4.94 | $3.02 | 169,065 | |
| $4.88 | -0.17 | -3.4% | $4.50 | $4.97 | $3.67 | 146,921 | |
| $5.05 | +1.34 | +36.1% | $3.98 | $5.15 | $3.80 | 99,654 | |
| $3.71 | +0.03 | +0.8% | $3.72 | $3.98 | $3.67 | 7,357 | |
| $3.68 | -0.24 | -6.1% | $3.94 | $3.94 | $3.59 | 11,696 | |
| $3.92 | -0.30 | -7.1% | $4.15 | $4.28 | $3.92 | 47,359 | |
| $4.22 | +0.11 | +2.7% | $4.16 | $4.22 | $4.16 | 2,300 | |
| $4.11 | +0.29 | +7.6% | $3.75 | $4.41 | $3.75 | 21,500 | |
| $3.82 | +0.20 | +5.5% | $3.51 | $3.98 | $3.51 | 8,400 | |
| $3.62 | +0.13 | +3.7% | $3.54 | $3.66 | $3.46 | 12,100 | |
| $3.49 | +0.35 | +11.1% | $3.07 | $3.66 | $3.07 | 56,400 | |
| $3.14 | +0.14 | +4.7% | $3.00 | $3.30 | $3.00 | 13,900 | |
| $3.00 | -0.29 | -8.8% | $3.17 | $3.32 | $3.00 | 27,400 | |
| $3.29 | -0.21 | -6.0% | $3.52 | $3.87 | $3.20 | 75,400 | |
| $3.50 | -0.40 | -10.3% | $4.04 | $4.04 | $3.47 | 167,000 | |
| $3.90 | -0.07 | -1.8% | $4.03 | $4.06 | $3.90 | 3,000 | |
| $3.97 | -0.02 | -0.5% | $4.02 | $4.05 | $3.92 | 4,900 | |
| $3.99 | +0.01 | +0.3% | $3.91 | $4.09 | $3.91 | 4,400 | |
| $3.98 | -0.37 | -8.5% | $4.38 | $4.50 | $3.98 | 11,900 | |
| $4.35 | +0.23 | +5.6% | $4.05 | $4.43 | $3.92 | 60,000 | |
| $4.12 | -0.01 | -0.2% | $4.13 | $4.66 | $3.92 | 64,500 | |
| $4.13 | +0.12 | +3.0% | $4.12 | $4.45 | $3.86 | 13,400 | |
| $4.01 | -0.14 | -3.4% | $4.16 | $4.29 | $3.95 | 35,300 | |
| $4.15 | +0.11 | +2.7% | $4.04 | $4.30 | $3.97 | 29,300 | |
| $4.04 | -0.18 | -4.3% | $4.05 | $4.30 | $3.85 | 47,500 | |
| $4.22 | -0.22 | -5.0% | $4.40 | $4.56 | $4.12 | 33,200 | |
| $4.44 | +0.40 | +9.9% | $4.00 | $4.64 | $4.00 | 47,300 | |
| $4.04 | -0.16 | -3.8% | $4.25 | $4.25 | $3.77 | 60,900 | |
| $4.20 | -0.20 | -4.5% | $4.40 | $4.42 | $4.14 | 40,200 | |
| $4.40 | -0.46 | -9.5% | $4.82 | $4.82 | $4.23 | 43,700 | |
| $4.86 | -0.35 | -6.7% | $5.23 | $5.23 | $4.59 | 86,900 | |
| $5.21 | -0.03 | -0.6% | $5.25 | $5.38 | $5.04 | 21,600 | |
| $5.24 | +0.24 | +4.8% | $5.01 | $5.30 | $5.00 | 29,700 | |
| $5.00 | 0.00 | 0.0% | $5.02 | $5.18 | $4.80 | 29,000 | |
| $5.00 | +0.10 | +2.0% | $4.94 | $5.18 | $4.87 | 46,500 | |
| $4.90 | -1.10 | -18.3% | $6.06 | $6.11 | $4.80 | 108,500 | |
| $6.00 | +0.07 | +1.2% | $5.94 | $6.22 | $5.90 | 17,200 | |
| $5.93 | -0.72 | -10.8% | $6.64 | $6.65 | $5.87 | 48,700 | |
| $6.65 | -0.47 | -6.6% | $7.01 | $7.20 | $6.33 | 67,600 | |
| $7.12 | +0.46 | +6.9% | $6.61 | $7.20 | $6.27 | 50,100 | |
| $6.66 | +0.34 | +5.4% | $6.32 | $6.80 | $6.25 | 52,800 | |
| $6.32 | +0.37 | +6.2% | $5.92 | $6.43 | $5.80 | 53,800 | |
| $5.95 | +0.20 | +3.5% | $5.80 | $6.17 | $5.51 | 44,400 | |
| $5.75 | +0.15 | +2.7% | $5.57 | $5.98 | $5.30 | 69,900 | |
| $5.60 | -0.09 | -1.6% | $5.70 | $5.79 | $5.45 | 63,500 | |
| $5.69 | -0.25 | -4.2% | $5.96 | $5.96 | $5.45 | 53,600 | |
| $5.94 | +0.12 | +2.1% | $5.84 | $6.07 | $5.59 | 64,600 | |
| $5.82 | +0.42 | +7.8% | $5.35 | $5.90 | $5.19 | 32,100 | |
| $5.40 | -0.82 | -13.2% | $6.19 | $6.19 | $4.70 | 132,300 | |
| $6.22 | +0.32 | +5.4% | $5.95 | $6.41 | $5.74 | 81,700 | |
| $5.90 | +0.14 | +2.4% | $5.81 | $5.94 | $5.36 | 42,000 | |
| $5.76 | +0.31 | +5.7% | $5.44 | $5.80 | $5.41 | 83,800 | |
| $5.45 | +0.46 | +9.2% | $4.82 | $5.55 | $4.73 | 125,800 | |
| $4.99 | +1.01 | +25.4% | $3.84 | $5.08 | $3.84 | 146,000 | |
| $3.98 | -0.41 | -9.3% | $4.11 | $4.37 | $3.98 | 48,600 | |
| $4.39 | +0.08 | +1.9% | $4.35 | $4.64 | $4.26 | 52,000 | |
| $4.31 | 0.00 | 0.0% | $4.36 | $4.49 | $4.11 | 64,800 | |
| $4.31 | +0.10 | +2.4% | $4.16 | $4.493 | $4.01 | 20,446 | |
| $4.21 | +0.23 | +5.8% | $3.89 | $4.35 | $3.89 | 53,256 | |
| $3.98 | -0.82 | -17.1% | $4.80 | $4.87 | $3.70 | 100,600 | |
| $4.80 | +0.75 | +18.5% | $4.07 | $4.99 | $4.07 | 178,700 | |
| $4.05 | +0.25 | +6.6% | $3.75 | $4.20 | $3.75 | 116,600 | |
| $3.80 | +0.16 | +4.4% | $3.64 | $3.94 | $3.54 | 122,100 | |
| $3.64 | +0.30 | +9.0% | $3.41 | $3.69 | $3.30 | 100,000 | |
| $3.34 | +0.05 | +1.5% | $3.30 | $3.39 | $3.20 | 51,500 | |
| $3.29 | +0.14 | +4.4% | $3.14 | $3.35 | $2.86 | 99,300 |
- Ticker
- NASDAQ:ADIL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis
Latest deck · October 2026
Merger or Acquisition (October 2026)
Merger or acquisition · 25 slides
Latest news
Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis
Oct 28, 2026
Closed $4.88 (-3.4%) on Oct 29, 2026
Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer
Oct 26, 2026
Closed $3.68 (-6.1%) on Oct 26, 2026
Amendment to Quarterly Report (Form 10-Q/A)
Oct 21, 2026
Closed $4.11 (+7.6%) on Oct 21, 2026
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
Oct 16, 2026
Closed $3.49 (+11.1%) on Oct 16, 2026
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Sep 30, 2026
Closed $4.13 (+3.0%) on Oct 1, 2026
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
Jun 16, 2026
Closed $2.54 (-10.9%) on Jun 16, 2026
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Jun 11, 2026
Closed $2.98 (+38.0%) on Jun 11, 2026
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
May 11, 2026
Closed $1.44 (+0.7%) on May 11, 2026
Financings
Private placement of prefunded warrants
Oct 28, 2026
Update: about US$32M
Buyers: Coastlands Capital (led the financing); Boxer Capital Management; Stonepine Capital Management; AuGC BioFund; Kern Capital
Insiders: Insiders and management participated
Use of proceeds: Fund operations into 2028, including IND-enabling studies and initiation of the Phase 1 trial of AT177 in ulcerative colitis
Decks
Merger or Acquisition (October 2026)
Merger or acquisition · 25 slides · October 2026
Merger or Acquisition (June 2026)
Merger or acquisition · 26 slides · June 2026
Investor Presentation (February 2026)
Investor deck · 18 slides · February 2026
Investor Presentation (January 2026)
Investor deck · 18 slides · January 2026
Adial Pharmaceuticals, Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 143 in all · newest Oct 28, 2026 · oldest 2020
- Decks
- 26 decks · latest October 2026
Where Adial Pharmaceuticals, Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ADIL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ADIL | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Adial Pharmaceuticals, Inc.